The recommended dosage of ACTEMRA for treatment of adult patients with COVID-19 is 8 mg per kg administered as a single 60-minute intravenous infusion. If clinical signs or symptoms worsen or do not improve after the first dose, one additional infusion of ACTEMRA may be administered at least...
The available data with ACTEMRA in pregnant women are insufficient to draw conclusions about drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. You may report side effects to the FDA at (800) FDA-1088 orwww.fda.gov/medwatch.You may also repor...
Tell your doctor if you are pregnant or plan to become pregnant. Women of childbearing potential should be advised to use adequate contraception during and for several months after treatment with Actemra. Actemra should not be used during pregnancy. However if there is a need to take Actemra whe...
Most common side effects in patients treated with Actemra: Patients should tell their doctor if they have these or any other side effect that bothers them or does not go away: Upper respiratory tract infections (like common cold and sinus infections) ...
The available data with ACTEMRA in pregnant women are insufficient to draw conclusions about drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. You may report side effects to the FDA at (800) FDA-1088 orwww.fda.gov/medwatch.You may also repor...